On the HCPLive Atopic Dermatitis condition center page, audiences can find a variety of coverage mediums for medical news and updates, including articles, video interviews, podcasts, and breaking news on dermatitis research, treatment, and drug development.
January 03, 2025
Video
Panelists discuss the pathophysiology of atopic dermatitis (AD), focusing on the role of type 2 inflammation, and explore how AD can serve as an entry point to the atopic march in children, leading to other allergic diseases such as food allergies, asthma, and allergic rhinitis, including early indicators that may predict future comorbidities.
December 23, 2024
Article
These data expanded upon limited real-world data on retention of dupilumab past 2 years of treatment for patients with atopic dermatitis.
December 19, 2024
Article
These interim data resulted from the JADE REAL study, with 72-week results suggesting rapid improvements in eczema severity for adults and adolescents.
December 19, 2024
Article
December 18, 2024
Article
In a recent study, tralokinumab demonstrates effectiveness and safety for treating moderate-to-severe atopic dermatitis in adults who are dupilumab naïve and non-naïve.
December 18, 2024
Article
Findings suggest an association between food allergies and atopic dermatitis control and persistence.
December 18, 2024
Article
A study showed parents of children with atopic dermatitis have an increased odds of taking medication to aid sleep.
December 17, 2024
Video
This interview featured a discussion with Browning regarding his team’s findings prior to the FDA approval of tapinarof cream 1% for atopic dermatitis.
December 16, 2024
Article
The submission of roflumilast’s supplemental New Drug Application to the FDA by Arcutis follows the conclusion of the INTEGUMENT-PED and INTEGUMENT-OLE studies.
December 16, 2024
Article
The approval of tapinarof cream (Vtama) for patients aged 2 years and older with eczema follows the positive findings in the ADORING trial program.